Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Heidelberg Pharma AG banner

Heidelberg Pharma AG
DUS:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
DUS:HPHA
Watchlist
Price: 2.55 EUR
Market Cap: €118.8m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

HPHA Price Targets Summary
Heidelberg Pharma AG

Wall Street analysts forecast HPHA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HPHA is 5.44 EUR with a low forecast of 5.39 EUR and a high forecast of 5.6 EUR.

HPHA Lowest Forecast
5.39 EUR
111% Upside
HPHA Average Forecast
5.44 EUR
113% Upside
HPHA Highest Forecast
5.6 EUR
120% Upside
Lowest Forecast
Price Target
5.39 EUR
111% Upside
Average Forecast
Price Target
5.44 EUR
113% Upside
Highest Forecast
Price Target
5.6 EUR
120% Upside
Heidelberg Pharma AG Competitors:
Price Targets
L
LGI
Lgi Ltd
39% Upside
NN
NextNav Inc
93% Upside
VYNE
Vyne Therapeutics Inc
204% Upside
AREC
American Resources Corp
195% Upside
L
LGI
Lgi Ltd
39% Upside
NN
NextNav Inc
93% Upside
VYNE
Vyne Therapeutics Inc
204% Upside
AREC
American Resources Corp
195% Upside

Revenue
Forecast

1% / Year
Past Growth
202% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss
1% / Year
Past Growth
202% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.

What are analyst estimates?

Gross Profit
Forecast

9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Heidelberg Pharma AG

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Heidelberg Pharma AG

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss

What are analyst estimates?

See Also

Summary
HPHA intrinsic value, competitors valuation, and company profile.
DCF Valuation
HPHA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HPHA stock valuation using valuation multiples.
Wall St Estimates
HPHA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HPHA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Heidelberg Pharma AG listings:
LSE • EUR
0QW5
 XETRA • EUR
HPHA
 F • EUR
HPHA
 XBER • EUR
HPHA
 XHAM • EUR
HPHA
 XMUN • EUR
HPHA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HPHA's stock price target?
Price Target
5.44 EUR

According to Wall Street analysts, the average 1-year price target for HPHA is 5.44 EUR with a low forecast of 5.39 EUR and a high forecast of 5.6 EUR.

What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%

Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.

Back to Top
ALPHA SPREAD
Follow us
Join 342,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett